Literature DB >> 10691972

Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.

B Stöckel1, J König, A T Nies, Y Cui, M Brom, D Keppler.   

Abstract

The multidrug resistance proteins MRP2 (symbol ABCC2) and MRP3 (symbol ABCC3) are conjugate export pumps expressed in hepatocytes. MRP2 is localized exclusively to the apical membrane and MRP3 to the basolateral membrane. MRP2 mRNA is expressed at a high level under normal conditions, whereas MRP3 mRNA expression is low and increases only when secretion across the apical membrane by MRP2 is impaired. We studied some of the regulatory properties of the two human genes using transient transfection assays with promoter-luciferase constructs in HepG2 cells and cloned fragments of 1229 nucleotides and 1287 nucleotides of the MRP2 and MRP3 5'-flanking regions, respectively. The sequence between nucleotides -517 and -197 was decisive for basal MRP2 expression. Basal promoter activity of MRP3 was only 4% of that measured for MRP2. At submicromolar concentrations, the histone deacetylase inhibitor trichostatin A reduced the MRP2 reporter gene activity and expression of the protein. Disruption of microtubules with nocodazole decreased gene and protein expression of MRP2 and increased MRP3 reporter gene activity. The genotoxic 2-acetylaminofluorene decreased the activity of the human MRP2 reporter gene construct, but increased MRP3 gene activity and enhanced the amounts of mRNA and protein of MRP2 and MRP3. Thus, regulation of the expression of these ATP-dependent conjugate export pumps is not co-ordinate, but in part inverse. The inverse regulation of the two MRP isoforms is consistent with their distinct localization, their different mRNA expression under normal and pathophysiological conditions, and their different directions of substrate transport in polarized cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691972     DOI: 10.1046/j.1432-1327.2000.01106.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression.

Authors:  Ludovic Martin; Vanessa Douet; Christopher M VanWart; Matthew B Heller; Olivier Le Saux
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Physiological Regulation of Drug Metabolism and Transport: Pregnancy, Microbiome, Inflammation, Infection, and Fasting.

Authors:  Edward T Morgan; Joseph L Dempsey; Sylvie M Mimche; Tracey J Lamb; Supriya Kulkarni; Julia Yue Cui; Hyunyoung Jeong; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2018-03-07       Impact factor: 3.922

3.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression.

Authors:  Vanessa Douet; Christopher M VanWart; Matthew B Heller; Sabrina Reinhard; Olivier Le Saux
Journal:  Biochim Biophys Acta       Date:  2006-08-11

Review 4.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

5.  Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.

Authors:  Valeska Vollrath; Ana M Wielandt; Mirentxu Iruretagoyena; Jose Chianale
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

6.  MRP3: a molecular target for human glioblastoma multiforme immunotherapy.

Authors:  Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

7.  Impact of basolateral multidrug resistance-associated protein (Mrp) 3 and Mrp4 on the hepatobiliary disposition of fexofenadine in perfused mouse livers.

Authors:  Xianbin Tian; Brandon Swift; Maciej J Zamek-Gliszczynski; Martin G Belinsky; Gary D Kruh; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2008-02-14       Impact factor: 3.922

8.  Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.

Authors:  Giulia Ghibellini; Elaine M Leslie; Gary M Pollack; Kim L R Brouwer
Journal:  Pharm Res       Date:  2008-05-30       Impact factor: 4.200

9.  Fasting induces nuclear factor E2-related factor 2 and ATP-binding Cassette transporters via protein kinase A and Sirtuin-1 in mouse and human.

Authors:  Supriya R Kulkarni; Ajay C Donepudi; Jialin Xu; Wei Wei; Qiuqiong C Cheng; Maureen V Driscoll; Delinda A Johnson; Jeffrey A Johnson; Xiaoling Li; Angela L Slitt
Journal:  Antioxid Redox Signal       Date:  2013-07-31       Impact factor: 8.401

10.  Flavone-resistant Leishmania donovani overexpresses LdMRP2 transporter in the parasite and activates host MRP2 on macrophages to circumvent the flavone-mediated cell death.

Authors:  Sayan Chowdhury; Rupkatha Mukhopadhyay; Sourav Saha; Amartya Mishra; Souvik Sengupta; Syamal Roy; Hemanta K Majumder
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.